XML 31 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data (Tables)
 12 Months Ended
Dec. 31, 2011
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]  
Quarterly Financial Data
The following table sets forth unaudited consolidated statements of income data for the eight quarters in the period ended December 31, 2012. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.
 
 
Quarter Ended
 
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
 
2012
 
2012
 
2012
 
2012
 
2011
 
2011
 
2011
 
2011
 
 
(Unaudited, In thousands, except share and per share information)
Revenues
 
$
99,040

 
$
50,484

 
$
34,939

 
$
66,264

 
$
61,130

 
$
39,746

 
$
50,585

 
$
20,795

Operating costs and expenses:
 
 

 
 

 
 

 
 
 
 

 
 

 
 

 
 
Cost of revenues:
 
 

 
 

 
 

 
 
 
 

 
 

 
 

 
 
Inventor royalties
 
7,594

 
9,573

 
5,032

 
3,829

 
13,089

 
8,588

 
15,592

 
6,458

Contingent legal fees
 
3,748

 
6,607

 
8,833

 
5,463

 
9,367

 
13,039

 
12,328

 
5,547

Litigation and licensing expenses - patents
 
3,381

 
5,268

 
5,973

 
6,969

 
3,538

 
3,761

 
3,501

 
2,205

Amortization of patents
 
5,126

 
5,393

 
10,412

 
18,088

 
3,772

 
2,600

 
1,946

 
1,427

Verdict insurance proceeds
 
—

 
—

 
—

 
—

 
—

 
—

 
(12,451
)
 
—

Verdict insurance proceeds related costs
 
—

 
—

 
—

 
—

 
—

 
—

 
7,661

 
—

Marketing, general and administrative expenses (including non-cash stock compensation expense)
 
13,731

 
11,903

 
11,914

 
16,535

 
9,981

 
8,302

 
8,748

 
8,662

Research, consulting and other expenses - business development
 
1,116

 
1,967

 
1,139

 
721

 
708

 
1,335

 
850

 
1,445

Total operating costs and expenses
 
34,696

 
40,711

 
43,303

 
51,605

 
40,455

 
37,625

 
38,175

 
25,744

Operating income (loss)
 
64,344

 
9,773

 
(8,364
)
 
14,659

 
20,675

 
2,121

 
12,410

 
(4,949
)
Total other income (expense)
 
56

 
102

 
(41
)
 
820

 
29

 
24

 
25

 
18

Income (loss) before provision for (benefit from) income taxes
 
64,400

 
9,875

 
(8,405
)
 
15,479

 
20,704

 
2,145

 
12,435

 
(4,931
)
(Provision for) benefit from income taxes
 
(14,747
)
 
(3,494
)
 
1,938

 
(5,757
)
 
(7,148
)
 
(306
)
 
(1,889
)
 
635

Net income (loss) including noncontrolling interests
 
49,653

 
6,381

 
(6,467
)
 
9,722

 
13,556

 
1,839

 
10,546

 
(4,296
)
Net (income) loss attributable to noncontrolling interests
 
275

 
(60
)
 
(152
)
 
101

 
(1,203
)
 
300

 
257

 
107

Net income (loss) attributable to Acacia Research Corporation
 
$
49,928

 
$
6,321

 
$
(6,619
)
 
$
9,823

 
$
12,353

 
$
2,139

 
$
10,803

 
$
(4,189
)
Net income (loss) per common share attributable to Acacia Research Corporation:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Basic income (loss) per share
 
$
1.13

 
$
0.13

 
$
(0.14
)
 
$
0.20

 
$
0.35

 
$
0.05

 
$
0.26

 
$
(0.10
)
Diluted income (loss) per share
 
$
1.09

 
$
0.13

 
$
(0.14
)
 
$
0.20

 
$
0.34

 
$
0.05

 
$
0.25

 
$
(0.10
)
Weighted-average number of shares outstanding, basic
 
44,367,499

 
47,944,193

 
48,332,878

 
48,335,865

 
35,182,811

 
40,994,082

 
41,292,819

 
41,418,470

Weighted-average number of shares outstanding, diluted
 
45,771,228

 
48,938,766

 
48,332,878

 
48,797,304

 
36,448,005

 
42,453,782

 
42,857,880

 
41,418,470